Tandem Diabetes Care soars after double Q3 beats

[Third Quarter Q3 Profits Stock Trading Chart 3D Background]
filo

* Tandem Diabetes Care is up ~16% in after-hours trading Thursday after posting beats [https://seekingalpha.com/news/4517898-tandem-diabetes-care-gaap-eps-of-0_31-beats-by-0_05-revenue-of-249_25m-beats-by-13_48m] on the top and bottom lines in its Q3 financial results.
* The company also reaffirmed its 2025 guidance. The revenue projection of $1B is inline with the consensus.
* In the quarter, Tandem narrowed its quarterly GAAP loss to ($0.31/share) from ($0.35.share) in the year-ago period.
* Although revenue only increased 2% YoY, the company achieved record sales in both the U.S. and internationally, and YoY margin improvement of 54% compared to 51% in Q3 2024.
* Cash, cash equivalents, and short-term investments at the end of the quarter were ~$319.1M compared to $438.3M on Dec. 31, 2024.

MORE ON TANDEM DIABETES CARE

* Tandem Diabetes Care, Inc. (TNDM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript [https://seekingalpha.com/article/4821549-tandem-diabetes-care-inc-tndm-presents-at-morgan-stanley-23rd-annual-global-healthcare]
* Tandem Diabetes Care: An Earnings Miss Confirms The Bear Case - Downgrade To Sell [https://seekingalpha.com/article/4811895-tandem-diabetes-care-earnings-miss-confirms-bear-case-downgrade-sell]
* Tandem Diabetes Care GAAP EPS of -$0.31 beats by $0.05, revenue of $249.25M beats by $13.48M [https://seekingalpha.com/news/4517898-tandem-diabetes-care-gaap-eps-of-0_31-beats-by-0_05-revenue-of-249_25m-beats-by-13_48m]
* Tandem Diabetes Care Q3 2025 Earnings Preview [https://seekingalpha.com/news/4515824-tandem-diabetes-care-q3-2025-earnings-preview]
* Seeking Alpha’s Quant Rating on Tandem Diabetes Care [https://seekingalpha.com/symbol/TNDM/ratings/quant-ratings]